dipyridamole drug pathway 2015-10-13T15:01:37Z PW:0002069 The pharmacokinetics and pharmacodynamics pathway of dipyridamole, a drug that inhibits the formation of blood clots via inhibition of platelet aggregation. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug. pathway vpetri antiplatelet drug pathway